Terns Pharmaceuticals Inc Obesity Franchise Webinar Transcript
Good morning, ladies and gentlemen, and welcome to the Terns Pharmaceuticals conference call. My name is Justin Ng, Director of Corporate Development and Investor Relations. As a reminder, this conference call is being recorded and a webcast of this call will be archived on the Terns website. At this time, all participants are in listen-only mode.
Following our presentation, we will open the line for a question-and-answer session. I would like to remind you that during this call, we will be making forward-looking statements that are subject to risks and uncertainties. Our actual results may differ materially from those described. We encourage you to review our risk factors in our most recent quarterly report on Form 10-Q, which can be found on our website. While we may elect to update these forward-looking statements in the future, we specifically disclaim any obligation to do so.
Now I'll turn the call over to Erin Quirk, President and Head of R&D.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |